NEOGENOMICS INC
For the period ended Dec 31, 2024. Filed Feb 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 18, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
| Table of Contents | NEOGENOMICS, INC. |
|---|
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Date: February 18, 2025 | NEOGENOMICS, INC. | |
|---|---|---|
| By: | /s/ Christopher M. Smith | |
| Name: | Christopher M. Smith | |
| Title: | Director and Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Table of Contents | NEOGENOMICS, INC. |
|---|
| Signatures | Title(s) | Date |
|---|---|---|
| /s/ Christopher M. Smith | Director and Chief Executive Officer (Principal Executive Officer) | February 18, 2025 |
| Christopher M. Smith | ||
| /s/ Jeffrey S. Sherman | Chief Financial Officer (Principal Financial Officer) | February 18, 2025 |
| Jeffrey S. Sherman | ||
| /s/ Gregory D. Aunan | Senior Vice President & Chief Accounting Officer(Principal Accounting Officer) | February 18, 2025 |
| Gregory D. Aunan | ||
| /s/ Lynn A. Tetrault | Chair of the Board | February 18, 2025 |
| Lynn A. Tetrault | ||
| /s/ Elizabeth A. Floegel | Director | February 18, 2025 |
| Elizabeth A. Floegel | ||
| /s/ Dr. Neil Gunn | Director | February 18, 2025 |
| Dr. Neil Gunn | ||
| /s/ Dr. Alison L. Hannah | Director | February 18, 2025 |
| Dr. Alison L. Hannah | ||
| /s/ Stephen M. Kanovsky | Director | February 18, 2025 |
| Stephen M. Kanovsky | ||
| /s/ Michael A. Kelly | Director | February 18, 2025 |
| Michael A. Kelly | ||
| /s/ Felicia Williams | Director | February 18, 2025 |
| Felicia Williams | ||
| /s/ David B. Perez | Director | February 18, 2025 |
| David B. Perez | ||
| /s/ Anthony P. Zook | Director | February 18, 2025 |
| Anthony P. Zook | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.